Arrowstreet Capital’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-101,587
| Closed | -$380K | – | 1249 |
|
|
2023
Q2 | $380K | Buy |
+101,587
| New | +$380K | ﹤0.01% | 1090 |
|
|
2022
Q3 | – | Sell |
-10,878
| Closed | -$77K | – | 1264 |
|
|
2022
Q2 | $77K | Buy |
+10,878
| New | +$77K | ﹤0.01% | 1195 |
|
|
2022
Q1 | – | Sell |
-102,775
| Closed | -$919K | – | 1190 |
|
|
2021
Q4 | $919K | Sell |
102,775
-75,780
| -42% | -$678K | ﹤0.01% | 1175 |
|
|
2021
Q3 | $6.26M | Buy |
178,555
+47,695
| +36% | +$1.67M | 0.01% | 880 |
|
|
2021
Q2 | $2.81M | Buy |
+130,860
| New | +$2.81M | ﹤0.01% | 1246 |
|